PALM BEACH, Fla. - TelAve -- Kat Marie Alvarez, RN, MBA, a nationally recognized healthcare leader, today announced the launch of KATALYST & Co., an integrated platform that unites strategic advisory services, capital deployment, and global operational execution. The company begins operations with $10 million in funding to drive its mission of advancing healthcare transformation through innovation and accountability.

Alvarez, who founded the company's now clinical division Katalyst Health in 2018, has spent decades leading change across the healthcare landscape. Her experience includes more than $5 billion in healthcare transactions, $2.7 billion in profit and loss responsibility, and the management of more than 12 million health plan members.

"I founded KATALYST & Co. to serve as a performance multiplier that helps providers, payers, sponsors, and tech innovators grow intelligently, deliver responsibly, and scale sustainably. With the $10 million initial round of funding, KATALYST & Co. is poised to shape the next era of healthcare, improving efficiency and innovation while honoring patients and those who care for them."

More on TelAve News

• Q4 2025 Outlook: JGCMGS Unveils High-Frequency Infrastructure for Italian and Global Markets
• UK Financial Ltd Announces Full Ecosystem To Erc-3643 "SEC-Ready" Tokens For All UK Financial Ltd Tokenized Projects
• Pushing the Wave Series Launches Premium Hardback Editions of 2017–2022 and 2023 Volumes
• 12G-SDI to Fiber Converter for Broadcast fiber systems
• ZEELOOL 2025 Black Friday and Cyber Monday Big Deals

For investors, including private equity firms and individual stakeholders, the platform delivers industry insight, market analysis, and operational expertise that ensures sustainable portfolio growth.

For payers, such as health plans and third-party administrators, KATALYST & Co. strengthens value-based care models to improve both financial and clinical outcomes.

For technology innovators, the firm provides commercialization support for health technology solutions, helping emerging technologies achieve scale and market readiness.

For provider groups, hospitals and healthcare systems, KATALYST & Co. helps design and implement strategies that elevate care delivery, operational efficiency, and patient experience.

A driving force behind KATALYST & Co.'s mission is the national shift toward value-based care (VBC), a model that rewards improved outcomes rather than the volume of services provided. As the Centers for Medicare & Medicaid Services (CMS) advances toward full VBC implementation by 2030, KATALYST & Co. equips organizations to adapt and thrive amid widespread industry disruption from artificial intelligence, policy shifts, consolidation, and competition.

More on TelAve News

• Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
• Bent Danholm Lists Contemporary Lakefront Residence in Winter Garden's Avalon Cove
• Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
• ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
• NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract

To guide clients through this transformation, KATALYST & Co. delivers expertise in strategic growth, investment advisory, global business process outsourcing and care delivery support, end-to-end value-based care infrastructure through Katalyst Health, and AI-powered technology enablement.

"We believe healthcare is a right, not a privilege," said Alvarez. "That conviction guides every partnership we take on and every system we help build."

Andrew Kaplan, Partner at Bain Capital, added, "Kat has a unique set of experiences that reach across the payer and care delivery ecosystem. Her patient-first mindset, combined with deep insights for where the market is heading, has consistently added value across multiple important efforts. She brings clarity and momentum to every engagement."